|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0015176,
umls-concept:C0017431,
umls-concept:C0021641,
umls-concept:C0025266,
umls-concept:C0027051,
umls-concept:C0030190,
umls-concept:C0032105,
umls-concept:C0033362,
umls-concept:C0035647,
umls-concept:C0086045,
umls-concept:C0205250,
umls-concept:C0332281,
umls-concept:C2603343
|
|
pubmed:issue |
11
|
|
pubmed:dateCreated |
2003-11-21
|
|
pubmed:abstractText |
Although the potential role of plasminogen activator inhibitor-1 (PAI-1) in the development of coronary artery disease is strongly supported by its biological characteristics, results of clinical studies remain controversial.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
1538-7933
|
|
pubmed:author |
pubmed-author:AillaudM FMF,
pubmed-author:AlessiM CMC,
pubmed-author:BoquistSS,
pubmed-author:Di MinnoGG,
pubmed-author:FrereCC,
pubmed-author:HIFMECH Study Group,
pubmed-author:HamstenAA,
pubmed-author:HaweEE,
pubmed-author:HumphriesS ESE,
pubmed-author:Juhan-VagueII,
pubmed-author:MargaglioneMM,
pubmed-author:MorangeP EPE,
pubmed-author:TornvallPP,
pubmed-author:TremoliEE,
pubmed-author:YudkinJ SJS
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
1
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2322-9
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:14629464-Case-Control Studies,
pubmed-meshheading:14629464-Europe,
pubmed-meshheading:14629464-Genotype,
pubmed-meshheading:14629464-Hemostasis,
pubmed-meshheading:14629464-Humans,
pubmed-meshheading:14629464-Insulin,
pubmed-meshheading:14629464-Insulin Resistance,
pubmed-meshheading:14629464-Male,
pubmed-meshheading:14629464-Middle Aged,
pubmed-meshheading:14629464-Myocardial Infarction,
pubmed-meshheading:14629464-Plasminogen Activator Inhibitor 1,
pubmed-meshheading:14629464-Polymorphism, Genetic,
pubmed-meshheading:14629464-Proinsulin,
pubmed-meshheading:14629464-Risk Factors
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
The plasminogen activator inhibitor-1 -675 4G/5G genotype influences the risk of myocardial infarction associated with elevated plasma proinsulin and insulin concentrations in men from Europe: the HIFMECH study.
|
|
pubmed:affiliation |
Laboratoire d'Hématologie, CHU Timone, Inserm EPI 99-36, Marseilles, France. ijuhan@ap-hm.fr
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
